Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Alzheimer's Disease

Trial Information

Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease

Official Title: A Multi-Center, Randomized, Double-Blind, Double-Dummy, Placebo- and Active-Controlled, Study to Evaluate the Safety and Efficacy of Huperzine A Sustained-Release Tablets in Patients With Mild to Moderate Alzheimer's Disease

Summary

The main purpose of this study is to evaluate the safety and efficacy of Huperzine A sustained release tablets in patients with mild to moderate Alzheimer's Disease.

Phase: Phase 2/Phase 3

Sponsor: Shandong Luye Pharmaceutical Co., Ltd.

Locations (1)

Country State City Zip Facility and Contact
China Shanghai Shanghai 200000 Shanghai Mental Health Center
Wang
861085865101

NCT ID:NCT01282619

Date Last Changed: January 24, 2011